What is Pharmacovigilance? An apple a day keeps the doctor away. But nothing ever keeps a researcher away. A researcher’s job is the backbone of medical sciences. Clinical research is, therefore, a driving factor for the healthy survival of human beings. It is common knowledge that any drug, prior to…
DIAGNOSTIC TEST FOR COVID-19 The coronavirus COVID -19 is posing major challenges for healthcare systems and medical institutions worldwide. An ability to rapidly diagnose the virus is of invaluable help in curbing its exponential spread in many countries. Bosch’s new, fully automated rapid test for COVID-19 can help medical facilities…
Gastroesophageal reflux disease (GERD) is when food or liquid travels from the stomach back up into the esophagus (the tube from the mouth to the stomach). This partially digested material is usually acidic and can irritate the esophagus, often causing heartburn and other symptoms. Our digestive system is supposed to…
WHAT IS INTELLECTUAL PROPERTY? Intellectual property refers to any; Creations of mind Inventions Literary & artistic works Symbols, names, and images used in commerce. Intellectual property is divided into two categories; Industrial property like patents for inventions, trademarks, industrial designs, and geographical indications. Copyright for literary works, architectural design, and…
Everything you need to know about N95 Masks As COVID-19 spreads around the world and cases continue to increase, there are multiple aspects of the worldwide pandemic to pay attention to. From knowing the difference between an epidemic and a pandemic, the signs and symptoms of COVID-19, and what hospital…
EMA During a virtual meeting held on 2nd April 2020, EMA’s human medicines committee (CHMP) gave recommendations on how to use the investigational antiviral medicine, Remdesivir for treating coronavirus disease (COVID-19) in compassionate use programmes in the European Union. Remdesivir has been shown to be active against SARS-CoV-2 and other types of coronavirus (i.e. SARS-CoV and MERS-CoV)…
The drug development process is a long, expensive, and failure-prone process that requires cutting-edge skills. It takes around 8-12 years on an average for a new drug to be developed, going through a course of rigorous trials, which if cleared can be approved for human use. Only as many as…
As you may know by now, the new drugs and clinical trials rules for 2019 are out, which are expected to promote clinical research in the country through a transparent process of yielding faster approvals. These changed rules will impact long term growth of CROs in India. As per the new…
Clinical Trial Monitoring is a very responsibility-filled duty that is performed to ensure that the rights, well-being, and safety of the clinical trial subjects are protected, and that the data coming out of a clinical trial is realistic and accurate. The monitoring is conducted by a sponsor representative, one like…
